Efficacy/Safety Study as H. Pylori Eradication of Triple Therapy for 7 Days Treatment

PHASE3CompletedINTERVENTIONAL
Enrollment

323

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Peptic Ulcer
Interventions
DRUG

Ilaprazole

10mg 2 BID( 2 times / day), before breakfast and dinner

DRUG

Pantoprazole

40mg, BID(2 times / day), before breakfast and dinner

Trial Locations (18)

Unknown

Soonchunhang University Hospital, Bucheon-si, Gyeonggi-do

Inje Busan Paik Hospital, Busan

Pusan National University Hospital, Busan

Kyungpook National University Medical Center, Daegu

Yeungnam University Medical Center, Daegu

Konyang University Hospital, Daejeon

Gachon University Gill Medical Center, Incheon

Wonkwang University of Medicine & Hospital, Jeollabuk-do

Chung Ang University Hospital, Seoul

Ewha Womens University Mokdong Hospital, Seoul

Inje University Seoul Paik Hospital, Seoul

Kangbuk Samsung Hospital, Seoul

KyungHee University Medical center, Seoul

Seoul Asan hoapital, Seoul

Seoul National University Hospital, Seoul

Severance Hospital, Seoul

The Catholic University of Korea, Seoul, Seoul

Wonju Severance Christian Hospital, Wonju-si, Gangwon-do

All Listed Sponsors
lead

Il-Yang Pharm. Co., Ltd.

INDUSTRY

NCT02084420 - Efficacy/Safety Study as H. Pylori Eradication of Triple Therapy for 7 Days Treatment | Biotech Hunter | Biotech Hunter